Harvard Business Review

JUNE 16, 2016

In July 2015, Novartis launched its new heart failure drug, Entresto, which Forbes in 2014 predicted would be a blockbuster — with expected sales of $10 billion annually — as the potential market in the US exceeds 5 million people with a heart failure condition. The failure stemmed from resistance in the U.S.

Planning 8

Planning Competitive Intelligence Pharmaceuticals Brand 8

Harvard Business Review

AUGUST 2, 2011

In reality, each country needs the other to succeed in order to thrive — to finance growth, secure export markets, train talent, transfer technology, and more. For example, pharmaceutical firms license compounds to each other and co-promote products in different markets.

Apparel 15

Apparel Pharmaceuticals Finance Licensing 15

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

NOVEMBER 9, 2011

What role does he or she play in the organization? Only two of the 37 organizations we studied had appointed more than two COOs in their history; in 27, the current COOs had only one predecessor; and in the remaining eight corporations, the incumbents were the companies' first COOs. Does your company have a COO today?

COO 12

COO Sample Telecommunications Automotive 12

Harvard Business Review

AUGUST 29, 2011

We discovered some of these pushes and pulls in our research for our upcoming book, Winning the War for Talent in Emerging Markets: Why Women Are the Solution. There's a sense that a woman is just working until she gets married, [that] she is not a long-term resource," said one senior finance professional. We do all of them.".

Stress 14

Stress Human Resources Pharmaceuticals Sharpe 14

Harvard Business Review

APRIL 5, 2012

If you spend much time around salespeople, it won't take long before you hear them griping about the issue that is the profession's biggest trouble spot: disagreement over the market potential of a group of accounts or a territory. In exit interviews, the people who leave imply they don't have enough market potential to succeed.".

Retail 9

Retail Incentives Tactics Pharmaceuticals 9

Harvard Business Review

SEPTEMBER 5, 2016

The concept is fairly straightforward: The parties define the result up front, agree on a baseline, work out how confident the organization is in delivering the result, and then specify the expectation and payment in the contract. Typically, the results are defined after conducting market research and engaging with customers.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

AUGUST 6, 2015

I made a career switch seven years ago, when I went from working as a reporter at the Financial Times , where I covered health care in the United States, to consulting — advising CEOs in the pharmaceutical industry on thought leadership and articulating their corporate strategies. You should also ask: How you should market them?

Career 8

Career Skills Health Care Pharmaceuticals 8

Harvard Business Review

AUGUST 23, 2018

In addition to signaling a strong economy, a tight labor market typically improves job prospects for groups with fewer skills and less experience, including teens. But for those who might not be college-bound, it appears that fewer pathways exist to enter the labor market. However, as of July 2018, the U.S. Many large U.S.

Short-term 8

Short-term Participative Long-term Career 8

Harvard Business Review

MAY 1, 2013

Without adequate financing, ministries of health and even private hospitals in developing countries often don''t have the resources needed to purchase diagnostic equipment, train workers, and ensure access to appropriate treatment. Three people die every minute from tuberculosis — a treatable and largely preventable disease.

Health Care 8

Health Care ROI NGO Long-term 8

Harvard Business Review

SEPTEMBER 13, 2011

Most organizations take the same stance. But only athletic events produce clear winners and losers in the short-term — and most organizations are not actively engaged in those. I've always been a big believer in using results as the differentiator between success and failure. You either achieve your goals or you don't.

Short-term 14

Short-term Pharmaceuticals Long-term Maturity 14

Harvard Business Review

MAY 15, 2013

While there is universal agreement that (1) it exists, and (2) that it plays a crucial role in shaping behavior in organizations, there is little consensus on what organizational culture actually is, never mind how it influences behavior and whether it is something leaders can change. Culture is a process of "sense-making" in organizations.

Incentives 8

Incentives Definition Pharmaceuticals System 8

Harvard Business Review

FEBRUARY 4, 2013

Just under 1,000 companies account for half of the world's market capitalization, Eccles notes. Breakthrough requires an end to systemic inequities by opening up processes, information - and markets. Perhaps surprisingly, two leading examples come from pharmaceutical companies. Breakthrough Finance.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

MARCH 24, 2011

Competitors whispered that Gupta was committing the most un-McKinsey-like of sins: cutting price to get into new markets. As the stock market began to take off, though, and options rained down on corporate execs, the compensation tables began to turn, certainly for the top ranks. While this may often be true in a strict I.Q.

McKinsey 14

McKinsey Consultative Waterman Intellectual Capital 14

Harvard Business Review

JANUARY 10, 2013

initiative — prohibitions against off-label marketing under the False Claims Act — swept through the pharmaceutical industry. Generally speaking, these multi-company issues have arisen from bad acts by individuals in the middle of the organization and do not appear to have been directed from the top of the corporation.

Finance 8

Finance Banking Press Release Pharmaceuticals 8

Harvard Business Review

NOVEMBER 20, 2015

He is poised to become the leader in this segment of a multi-billion dollar market. Compliance is crucial for pharmaceutical makers such as Abbott and Amgen – a “ Form 483 ” warning from an FDA inspector can shut down a drug facility in an instant and even land top executives in jail.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 19, 2016

This logic and the institutions that reinforce it, like competitive markets and the rule of law, have transformed the world and lifted billions of people from poverty. Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. How should you make this decision?

ROI 8

ROI Long-term Conflict of Interest Pharmaceuticals 8

Harvard Business Review

JANUARY 26, 2016

And yet for almost every company that uses CI in their decision-making, there’s another that disregards CI’s mix of industry analysis, rival positions, and market insight to their detriment. and European corporations, from CI-trained analysts in marketing, business development, strategy, R&D, finance, and other fields.

Competitive Intelligence 8

Competitive Intelligence Company CAPEX Analysis 8

Harvard Business Review

MARCH 6, 2014

His answer is that in a news market overflowing with facts, facts by themselves go unsold; they require a story—and that story, he says mischievously, needs some kind of bias on the part of the author, “a pair of lenses that slide over reality and aim to bring it more clearly into focus.” Where should all this go in our minds?”.

Peer Review 8

Peer Review Review Industry Wilde 8